Comparative efficacy of preprandial or postprandial Humalog® Mix75/25™ versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus

Clinical Therapeutics

Volumn 24, Issue 1, 2002, Pages 73-86

  Herz, Matthias ^a,f   Sun, Bin ^a   Milicevic, Zvonko ^b   Erickson, Pamella ^a   Fövènyi, Jozsef ^c   Grzywa, Marek ^d   Pelikanova, Terezie ^e  

^a ELI LILLY AND COMPANY   (United States)

^b Lilly Area Medical Center   (Austria)

^c Peterfy Sandor Teaching Hospital   (Hungary)

^d Oddzial Wewnetrzny ^*  (Poland)

^e INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^f LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Elderly patients; Insulin pens; Oral agent failure; Postprandial insulin lispro; Type 2 diabetes mellitus

Indexed keywords

GLIBENCLAMIDE; GLYCOSYLATED HEMOGLOBIN; HUMALOG MIX 75/25; INSULIN LISPRO; SULFONYLUREA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; WEIGHT GAIN;

EID: 0036159429     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)85006-8     Document Type: Article

References (28)

1. Antidiabetic treatment trends in a cohort of elderly people with diabetes: The cardiovascular health study, 1989-1997
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
3. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
4. Pharmacologic management of type 2 diabetes in the elderly: Overview of treatment options
5. Do diabetic patients inject accurate doses of insulin?
6. Accuracy of insulin injection in elderly patients
7. Diabetes in the elderly - A neglected area?
8. Use of premixed insulin among the elderly. Reduction of errors in patient preparation of mixtures
9. Maximizing drug compliance in the elderly. Tips for staying on top of your patients' medication use
10. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin
11. Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients
12. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lisproprotamine formulations, insulin lispro Mix25 and insulin lispro Mix50
13. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation
14. Improved postprandial glycemic control with Humalog® Mix75/25™ after a standard test meal in patients with type 2 diabetes mellitus
15. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy
16. Optimal time of administration of insulin lispro. Importance of meal composition
17. Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients
18. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
19. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: Results from the Third National Health and Nutrition Examination Survey
20. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
21. Study design, progress and performance
22. United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus
23. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu heart program
24. Risk factors for myocardial infarction and death in newly detected NIDDM: The diabetes intervention study, 11-year follow-up
25. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men
26. High blood glucose concentration is a risk factor for mortality in middle-aged non-diabetic men: 20-Year follow-up in the Whitehall study, the Paris prospective study, and the Helsinki policemen study
27. Improved glycaemic control with Humalog Mix25 compared with human insulin 30/70 in patients with type 2 diabetes
28. Overview of medications used to treat type 2 diabetes